期刊文献+

排石颗粒合坦索罗辛治疗体外冲击波碎石后输尿管结石疗效观察 被引量:7

Treatment of Tamsulosin with Pai Shi Ke Li for Uretera Stone after the Therapy of ESWL
下载PDF
导出
摘要 [目的]研究排石颗粒联用坦索罗辛治疗体外冲击波碎石术(ESWL)后的输尿管结石的临床疗效。[方法]2009年1月至2010年10月200例输尿管结石患者分为实验组和对照组各100例,两组患者经ESWL后均饮水2L/d,常规抗感染,止血处理,实验组给予排石颗粒联用坦索罗辛治疗;对照组仅口服排石颗粒。每例患者治疗观察期不超过2周,观察结石排出率、结石排出时间、典型肾绞痛再次发生率。[结果]实验组总排石率(78%)、排石时间(2~8d)、肾绞痛再发生率(5%)等均优于对照组,差异有统计学意义(P<0.05)。[结论]排石颗粒联用坦索罗辛用于辅助排出ESWL后的输尿管结石,减少肾绞痛发作,疗效肯定,便于推广应用。 [Purpose] To observe the curative effect of Pai Shi Ke Li with tamsulosin to treat ureteral stone after the therapy of extracorporeal shock wave lithotripsy(ESWL).[Methods] Experimental group A and control group B were established.Two groups of drinking water 2L a day after ESWL,conventional anti-infection,bleeding treatment.100 patients with ureteral stones were treated using Pai Shi Ke Li matching with tamsulosin.In the control group B,100 patients were treated with Pai Shi Ke Li alone.The time was no more than 2 weeks,we observed the exclusion rate,exclusion time of the ureteral stone and the recurrence of renenal colic.[Results] It was found that the stone exclusion rate of the experimental group A(78%)was higher than that of the control group B(56%).There was satatistical difference between the two groups.The exclusion time in the experimental group and control group was 2~8(5±3)days and 8~14(11±3)days respectively.Typical of the incidences of renal colic again were 5% and 15% in the experimental group and the control group respectively.[Conclusions] Tt is suggested that Pai Shi Ke Li in cooperation with tamsulosin can be used to assist the exclusion of uretera stone and reduce the recurrence of renal colic.It has good curative effect to popularize.
出处 《浙江中医药大学学报》 CAS 2011年第6期871-873,共3页 Journal of Zhejiang Chinese Medical University
关键词 输尿管结石 体外冲击波碎石 排石颗粒 坦索罗辛 ureteral stone ESWL Pai Shi Ke Li Tamsulosin
  • 相关文献

参考文献6

二级参考文献11

  • 1李仪奎.中药药理试验方法学[M].上海:上海科学技术出版社,1991.496.
  • 2孙传兴.临床疾病诊断依据治愈好转标准[S](第2版)[M].北京:人民军医出版社,1999.356.
  • 3Morse RM, Resnick MI. Ureteral calculi: natural history and treatment in an era of advanced technology. J Urol, 1991, 145 : 263-265.
  • 4Bajor G. Beta-blocking agent facilitating the spontaneous passage of ureteral stones. Int Urol Nephrol, 1990, 22: 33-36.
  • 5Borghi L, Meschi T, Amato F, et al. Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomized, doubleblind, placebo-controlled study. J Urol, 1994, 152: 1095-1098.
  • 6Morita T, Ando M, Kihara K, et al. Function and distribution of autonomic receptors in canine ureteral smooth muscle. Neurourol Urodyn, 1994, 13: 315-321.
  • 7Cervenakov I, Fillo J, Mardiak J, et al. Speedy elimination of ureterolithiasis in lower part of ureters with the alpha 1-blocker - - Tamsulosin. Int Urol Nephrol, 2002, 34: 25-29.
  • 8Porpiglia F, Ghignone G, Fiofi C, et al. Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol, 2004, 172:568 -571.
  • 9Dellabella M, Milanese G, Muzzonigro G. Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol,2003, 170 : 2202-2205.
  • 10Yilmaz E, Batislam E, Basar MM, et al. The comparison and efficacy of 3 different alphal-adrenergic blockers for distal ureteral stones.J Urol, 2005, 173: 2010-2012.

共引文献117

同被引文献57

  • 1柳春兴,邢建国.排石颗粒的药理作用研究[J].中国现代药物应用,2007,1(9):33-34. 被引量:15
  • 2段良斌,胡仁广,张国顺.坦索罗辛联合排石颗粒治疗输尿管下段结石48例临床分析[J].吉林医学,2013,34(13):2495-2495. 被引量:2
  • 3毛康荣,陈国强.HPLC测定排石颗粒中芦丁的含量[J].中国中药杂志,2004,29(7):707-707. 被引量:5
  • 4张丽,朴晋华,张蕻.排石颗粒主要药效学研究[J].中国药物与临床,2005,5(7):532-533. 被引量:23
  • 5Küpeli B,Irkilata L,Gürocak S.Does tamsulosin enhance lower ureteral tone clearance with or without shock wave lithotripsy[J].Urology.2004,64(6):1111-1115.
  • 6陈孝平,汪建平.外科学[M].第8版.北京:人民卫生出版社,2013.
  • 7Lin E, Ho L, Lin MS, et al. Wu-Ling-San formula prophylaxisagainst recurrent calcium oxalate nephrolithiasis a prospectiverandomized controlled trial [ J ]. Afr Tradit Complement AltemMed ,2013,10:199-209.
  • 8Rodgers AL, Webber D, Ramsout R, et al. Herbal preparationsaffect the kinetic factors of calcium oxalate crystallization insynthetic urine : implications for kidney stone therapy [ J ].Urolithiasis,2014,42:221 -225.
  • 9原章二,逸見由紀子.尿路結石症仁用薬[J].泌尿器夂7,2013,18:64-69.
  • 10Ogama Y, Takahashi S, Kitagawa R. Effect of herb medicines forurolithiasis on urinary oxalate excretion in rats [ J ]. HinyokikaKiyo,1983,29:1269-1271.

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部